Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000263441

Medchemexpress LLC Linzagolix | 935283-04-8 | 99.7% | 508.4 g/mol | C22H15F3N2O7S | 5 MG
SDP

Catalog No. 5000263441
Encompass_Preferred

Linzagolix is a non-peptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist used in laboratory research into estrogen-dependent conditions such as uterine fibroids, endometriosis, and adenomyosis. Supplied as a small, high-purity solid for research use only (not for human or veterinary use).

  • Non-peptide, orally active GnRH antagonist
  • Applicable to uterine fibroids, endometriosis, and adenomyosis research
  • High chemical purity suitable for analytical and pharmacological studies
  • Supplied in a small 5 mg pack for assay development and pilot studies
  • Molecular weight 508.4 g/mol

Catalog No. 50-002-63441 Supplier Medchemexpress LLC Supplier No. HY1090935MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Linzagolix is a non-peptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist used in laboratory research into estrogen-dependent conditions such as uterine fibroids, endometriosis, and adenomyosis. Supplied as a small, high-purity solid for research use only (not for human or veterinary use).

  • Non-peptide, orally active GnRH antagonist
  • Applicable to uterine fibroids, endometriosis, and adenomyosis research
  • High chemical purity suitable for analytical and pharmacological studies
  • Supplied in a small 5 mg pack for assay development and pilot studies
  • Molecular weight 508.4 g/mol

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.